Rapid Expansion in Exosome-Based Cancer Therapy CDMO Market to Reach New Heights by 2034
HealthcareThe global exosome-based cancer therapy contract development and manufacturing organization (CDMO) market is witnessing rapid growth, propelled by advancements in exosome technology, rising cancer prevalence, and increasing demand for personalized therapies. Expected to grow at a robust CAGR from 2025 to 2034, this market is transforming cancer treatment landscapes with precise drug delivery and innovative […]